http://purl.uniprot.org/citations/16033969 | http://www.w3.org/2004/02/skos/core#exactMatch | http://purl.uniprot.org/pubmed/16033969 |
http://purl.uniprot.org/citations/16033969 | http://xmlns.com/foaf/0.1/primaryTopicOf | https://pubmed.ncbi.nlm.nih.gov/16033969 |
http://purl.uniprot.org/citations/16033969 | http://purl.uniprot.org/core/author | "Lin Y.L."xsd:string |
http://purl.uniprot.org/uniprot/#_Q96AZ6-citation-16033969 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/16033969 |
http://purl.uniprot.org/citations/16033969 | http://purl.uniprot.org/core/author | "Espert L."xsd:string |
http://purl.uniprot.org/citations/16033969 | http://www.w3.org/1999/02/22-rdf-syntax-ns#type | http://purl.uniprot.org/core/Journal_Citation |
http://purl.uniprot.org/uniprot/Q96AZ6#attribution-8AEC5C7F995C4AA3FBCE1BF0DA88BC6D | http://purl.uniprot.org/core/source | http://purl.uniprot.org/citations/16033969 |
http://purl.uniprot.org/citations/16033969 | http://purl.uniprot.org/core/author | "Benkirane M."xsd:string |
http://purl.uniprot.org/citations/16033969 | http://purl.uniprot.org/core/author | "Degols G."xsd:string |
http://purl.uniprot.org/citations/16033969 | http://purl.org/dc/terms/identifier | "doi:10.1099/vir.0.81074-0"xsd:string |
http://purl.uniprot.org/citations/16033969 | http://purl.uniprot.org/core/author | "Vincent T."xsd:string |
http://purl.uniprot.org/uniprot/Q96AZ6 | http://purl.uniprot.org/core/citation | http://purl.uniprot.org/citations/16033969 |
http://purl.uniprot.org/citations/16033969 | http://purl.uniprot.org/core/name | "J. Gen. Virol."xsd:string |
http://purl.uniprot.org/citations/16033969 | http://purl.uniprot.org/core/author | "Mechti N."xsd:string |
http://purl.uniprot.org/citations/16033969 | http://purl.uniprot.org/core/date | "2005"xsd:gYear |
http://purl.uniprot.org/citations/16033969 | http://purl.uniprot.org/core/volume | "86"xsd:string |
http://purl.uniprot.org/citations/16033969 | http://purl.uniprot.org/core/title | "Interferon-induced exonuclease ISG20 exhibits an antiviral activity against human immunodeficiency virus type 1."xsd:string |
http://purl.uniprot.org/citations/16033969 | http://purl.uniprot.org/core/pages | "2221-2229"xsd:string |